MACROPHAGE PHARMA LIMITED logo

MACROPHAGE PHARMA LIMITED

Empowering the immune system to combat cancer with precision-targeted therapies

est. 2014

VS
NBE-Therapeutics AG logo

NBE-Therapeutics AG

Next generation antibody drug conjugates

48 employees · est. 2012 · Basel, Switzerland

NBE-Therapeutics AG is the older company (2014 vs 2012).

Side-by-Side Comparison

MACROPHAGE PHARMA LIMITED NBE-Therapeutics AG
Founded
2014 2012 older
Headquarters
Not tracked yet Basel, Switzerland
Employees
Not tracked yet 48
Industry
Biotechnology, Pharmaceutical Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A Series C
Total Funding
$9.00M Not tracked yet
Funding Rounds
1 Not tracked yet
Services
Not tracked yet Development of Antibody-Drug Conjugates, Research and Development in Oncology, Clinical Trials for Cancer Treatments, Biopharmaceutical Innovation
Target Customers
Not tracked yet Cancer Patients, Healthcare Providers, Oncologists, Medical Researchers
Taxonomy
Immuno-oncology, Cancer Treatment, Immune System, Precision-targeted Therapies, Tumor-associated Macrophages, Small Molecule Drugs, Treatment Discovery, Immune Response Activation, Tumor Therapy, Novel Therapies, Immune System Enhancement, Anti-tumor Immune Responses, Drug Delivery Technology, Cancer Research, Biopharmaceutical Company Oncology Treatments, Antibody Drug Conjugates, Solid Tumors, Immune Oncology, Cancer Therapies, Biotech, ADC Platform, Immunological Anti-Tumor Effect, Anthracycline Payload, Immune-Stimulatory Therapies, Targeted Medicines, Pharmaceutical Development, Cancer Patient Solutions, Innovative Technologies, Clinical Pipeline
Website
macrophagepharma.com nbe-therapeutics.com
MACROPHAGE PHARMA LIMITED logo

About MACROPHAGE PHARMA LIMITED

MACROPHAGE PHARMA LIMITED is an immuno-oncology company established in 2014 with the slogan, "Empowering the immune system to combat cancer with precision-targeted therapies." Specializing in Biotechnology and Pharmaceutical industries, the company is dedicated to finding and developing new treatmen...

NBE-Therapeutics AG logo

About NBE-Therapeutics AG

NBE-Therapeutics AG, founded in 2012 and headquartered in Switzerland, is pioneering the development of next-generation antibody drug conjugates (ADCs) with a particular focus on oncology treatments. Their slogan, “Next generation antibody drug conjugates,” encapsulates their mission to enhance canc...

We will tell you when either one moves

BounceWatch watches MACROPHAGE PHARMA LIMITED and NBE-Therapeutics AG for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at MACROPHAGE PHARMA LIMI... and NBE-Therapeutics AG — by email.

Frequently Asked Questions

MACROPHAGE PHARMA LIMITED — Empowering the immune system to combat cancer with precision-targeted therapies. NBE-Therapeutics AG — Next generation antibody drug conjugates. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
MACROPHAGE PHARMA LIMITED has raised $9.00M while NBE-Therapeutics AG has raised undisclosed funding.
MACROPHAGE PHARMA LIMITED and NBE-Therapeutics AG operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare MACROPHAGE PHARMA LIMITED with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at MACROPHAGE PHARMA LIMITED on 12 Sep 2024, and NBE-Therapeutics AG on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes